12:17 PM EST - BELLUS Health Inc. : Announced that Roberto Bellini, BELLUS Health's President and Chief Executive Officer, will provide a corporate overview of the Company, including BLU-5937, its lead program for chronic cough, at the upcoming Biotech Showcase™ 2018 Conference on Tuesday, January 9 in San Francisco, CA, at the Hilton San Francisco Union Square. BELLUS Health Inc.
shares T.BLU are trading unchanged at $0.38.
